Fungal infections in immunocompromised patients

Mycoses

Volumn 54, Issue SUPPL. 4, 2011, Pages 1-3

  Sganga, Gabriele ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN;

CANCER PATIENT; EDITORIAL; FUSARIOSIS; HIGH RISK PATIENT; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; INVASIVE ASPERGILLOSIS; INVASIVE CANDIDIASIS; PRIORITY JOURNAL; SURGICAL PATIENT; SYSTEMIC MYCOSIS;

ANTIFUNGAL AGENTS; HUMANS; IMMUNOCOMPROMISED HOST; MYCOSES; OPPORTUNISTIC INFECTIONS;

EID: 82455172186     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2011.02134.x     Document Type: Editorial

References (24)

1. Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004; 42: 4419-31.
2. Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijleven N. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother 2011; 66(Suppl 1): i5-14.
3. Walsh TJ, Anaissie EJ, Denning DW et al. Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-60.
4. Darouiche RO. Candida in the ICU. Clin Chest Med 2009; 30: 287-93.
5. Sganga G. Clinical aspects of invasive candidiasis in the surgical patient. Drugs 2009; 69(Suppl 1): 29-32.
6. Ruhnke M, Böhme A, Buchheidt D et al. Diagnosis of invasive fungal infections in hematology and oncology-guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO). Ann Oncol 2011; in press (doi:). Published online 23 September 2011.
7. Guery BP, Arendrup MC, Auzinger G et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med 2009; 35: 55-62.
8. Grossi PA. Clinical aspects of invasive candidiasis in solid organ transplant recipients. Drugs 2009; 69(Suppl 1): 15-20.
9. Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007; 45: 205-16.
10. Dean DA, Burchard KW. Fungal infection in surgical patients. Am J Surg 1996; 171: 374-82.
11. Barnes RA. Early diagnosis of fungal infection in immunocompromised patients. J Antimicrob Chemother 2008; 61(Suppl 1): i3-i6.
12. Singh N, Husain S. Invasive aspergillosis in solid organ transplant recipients. Am J Transplant 2009; 9(Suppl 4): S180-91.
13. Guery BP, Arendrup MC, Auzinger G et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment. Intensive Care Med 2009; 35: 206-14.
14. Maertens J, Vrebos M, Boogaerts M. Assessing risk factors for systemic antifungal infections. Eur J Can Care 2001; 10: 56-62.
15. Calandra T, Marchetti O. Clinical trials of antifungal prophylaxis among patients undergoing surgery. Clin Infect Dis 2004; 39(Suppl 4): S185-92.
16. Chamilos G, Luna M, Lewis RE et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 2006; 91: 986-9.
17. León C, Ruiz-Santana S, Saavedra P et al. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006; 34: 730-7.
18. Posteraro B, Torelli R, De Carolis E et al. Update on the laboratory diagnosis of invasive fungal infections. Mediterr J Hematol Infect Dis 2011; 3: e2011002.
19. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-35.
20. Flückiger U, Marchetti O, Bille J et al. Treatment options of invasive fungal infections in adults. Swiss Med Wkly 2006; 136: 447-63.
21. Vazquez JA, Sobel JD. Anidulafungin: a new echinocandin. Clin Infect Dis 2006; 43: 215-22.
22. Raash RH. Anidulafungin: a review of a new echinocandin antifungal agent. Expert Rev Anti Infect Ther 2004; 2: 499-508.
23. Anidulafungin summary of product characteristics, 2011. URL
24. Halawa A, Henry PD, Sarubbi FA. Candida endocarditis associated with cardiac rhythm management devices: review with current treatment guidelines. Mycoses 2011; 54: e168-74.